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Background
One of the big roadblocks in development of HIV-1/AIDS
vaccines is the enormous diversity of HIV-1, which could
limit the value of any HIV-1 vaccine candidate currently
under test.
Methods
To address the HIV-1 variation, we designed a novel T cell
immunogen, designated HIVconsv, by assembling the 14
most conserved regions of the HIV-1 proteome into one
chimaeric protein. Each segment is a consensus sequence
from one of the four major HIV-1 clades A, B, C and D,
which alternate to ensure equal clade coverage. The gene
coding for the HIVconsv protein was inserted into a
number of vaccine vectors, which were used in a multiple
heterologous prime-boost combination.
Results
Complex vaccination regimen induced strong, broad,
polyfunctional HIV-1-specific CD8 and CD4 T cell
responses non-human primates.
Conclusion
This vaccine approach provides an attractive and testable
alternative for overcoming the HIV-1 variability, while
focusing T cell responses on regions of the virus that are
less likely to mutate and escape. Furthermore, this immu-
nogen has merit in its simplicity. The potential of complex
heterologous regimen will be discussed. Phase I clinical
trials in healthy and HIV-1-infected individuals testing
HIVconsv vaccines have been funded and are under prep-
aration.
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